{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T12:23:14Z","timestamp":1793622194235,"version":"4.5.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100018557","name":"Science and Technology Project of Nantong City","doi-asserted-by":"publisher","award":["JC22022023"],"award-info":[{"award-number":["JC22022023"]}],"id":[{"id":"10.13039\/501100018557","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00262-023-03564-7","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T19:02:38Z","timestamp":1698778958000},"page":"4293-4308","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Tumor-associated neutrophils upregulate PANoptosis to foster an immunosuppressive microenvironment of non-small cell lung cancer"],"prefix":"10.1007","volume":"72","author":[{"given":"Qin","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runtian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"key":"3564_CR1","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Fuchs HE, et al. (2022)Cancer statistics, CA: a cancer journal for clinicians, 72: 7\u201333","DOI":"10.3322\/caac.21708"},{"key":"3564_CR2","unstructured":"Treatment choices for non-small cell lung cancer, by stage. https:\/\/www.cancer.org\/cancer\/lung-cancer\/treating-non-small-cell\/by-stage.html"},{"key":"3564_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejca.2016.12.041","volume":"78","author":"EG Leprieur","year":"2017","unstructured":"Leprieur EG, Dumenil C, Julie C, Giraud V, Dumoulin J, Labrune S, Chinet T (2017) Immunotherapy revolutionises non-small-cell lung cancer therapy: Results, perspectives and new challenges. European J Cancer 78:16\u201323","journal-title":"European J Cancer"},{"key":"3564_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40364-021-00341-5","volume":"10","author":"J Zhang","year":"2022","unstructured":"Zhang J, Veeramachaneni N (2022) Targeting interleukin-1\u03b2 and inflammation in lung cancer. Biomark Res 10:5","journal-title":"Biomark Res"},{"key":"3564_CR5","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3389\/fimmu.2020.00940","volume":"11","author":"A Labani-Motlagh","year":"2020","unstructured":"Labani-Motlagh A, Ashja-Mahdavi M, Loskog A (2020) The tumor microenvironment: a milieu hindering and obstructing antitumor immune responses. Front Immunol 11:940","journal-title":"Front Immunol"},{"key":"3564_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3892\/ol.2022.13588","volume":"25","author":"J Zhou","year":"2023","unstructured":"Zhou J, Liu H, Jiang S et al (2023) Role of tumor-associated neutrophils in lung cancer (review). Oncol Lett 25:2","journal-title":"Oncol Lett"},{"key":"3564_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.553967","volume":"11","author":"L Wu","year":"2020","unstructured":"Wu L, Zhang XH (2020) Tumor-associated neutrophils and macrophages-heterogenous but not chaotic. Front Immunol 11:553967","journal-title":"Front Immunol"},{"key":"3564_CR8","first-page":"483","volume":"66","author":"TL Gerrard","year":"1981","unstructured":"Gerrard TL, Cohen DJ, Kaplan AM (1981) Human neutrophil-mediated cytotoxicity to tumor cells. J Natl Cancer Inst 66:483\u2013488","journal-title":"J Natl Cancer Inst"},{"key":"3564_CR9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nrc.2016.52","volume":"16","author":"SB Coffelt","year":"2016","unstructured":"Coffelt SB, Wellenstein MD, de Visser KE (2016) Neutrophils in cancer: neutral no more. Nat Rev Cancer 16:431\u2013446","journal-title":"Nat Rev Cancer"},{"key":"3564_CR10","doi-asserted-by":"publisher","first-page":"5859","DOI":"10.1073\/pnas.86.15.5859","volume":"86","author":"DR Welch","year":"1989","unstructured":"Welch DR, Schissel DJ, Howrey RP et al (1989) Tumor-elicited polymorphonuclear cells, in contrast to \u201cnormal\u201d circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells. Proc Natl Acad Sci USA 86:5859\u20135863","journal-title":"Proc Natl Acad Sci USA"},{"key":"3564_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","volume":"16","author":"ZG Fridlender","year":"2009","unstructured":"Fridlender ZG, Sun J, Kim S et al (2009) Polarization of tumor-associated neutrophil phenotype by tgf-beta: \u201cN1\u201d versus \u201cn2\u201d tan. Cancer Cell 16:183\u2013194","journal-title":"Cancer Cell"},{"key":"3564_CR12","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1073\/pnas.0712185105","volume":"105","author":"F Shojaei","year":"2008","unstructured":"Shojaei F, Singh M, Thompson JD et al (2008) Role of bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression. Proc Natl Acad Sci USA 105:2640\u20132645","journal-title":"Proc Natl Acad Sci USA"},{"key":"3564_CR13","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/S0002-9440(10)63580-8","volume":"163","author":"H Tazawa","year":"2003","unstructured":"Tazawa H, Okada F, Kobayashi T et al (2003) Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression. Am J Pathol 163:2221\u20132232","journal-title":"Am J Pathol"},{"key":"3564_CR14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3892\/mco.2017.1342","volume":"7","author":"Y Yu","year":"2017","unstructured":"Yu Y, Qian L, Cui J (2017) Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: a meta-analysis of 7,219 patients. Mol Clin Oncol 7:498\u2013506","journal-title":"Mol Clin Oncol"},{"key":"3564_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.598873","volume":"10","author":"NT Sebastian","year":"2020","unstructured":"Sebastian NT, Raj R, Prasad R et al (2020) Association of pre- and posttreatment neutrophil-lymphocyte ratio with recurrence and mortality in locally advanced non-small cell lung cancer. Front Oncol 10:598873","journal-title":"Front Oncol"},{"key":"3564_CR16","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.lungcan.2017.07.024","volume":"111","author":"S Diem","year":"2017","unstructured":"Diem S, Schmid S, Krapf M et al (2017) Neutrophil-to-lymphocyte ratio (nlr) and platelet-to-lymphocyte ratio (plr) as prognostic markers in patients with non-small cell lung cancer (nsclc) treated with nivolumab. Lung Cancer (Amsterdam, Netherlands) 111:176\u2013181","journal-title":"Lung Cancer (Amsterdam, Netherlands)"},{"key":"3564_CR17","doi-asserted-by":"publisher","first-page":"72184","DOI":"10.18632\/oncotarget.12360","volume":"7","author":"M Rakaee","year":"2016","unstructured":"Rakaee M, Busund LT, Paulsen EE et al (2016) Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer. Oncotarget 7:72184\u201372196","journal-title":"Oncotarget"},{"key":"3564_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030806","volume":"7","author":"HL Rao","year":"2012","unstructured":"Rao HL, Chen JW, Li M et al (2012) Increased intratumoral neutrophil in colorectal carcinomas correlates closely with malignant phenotype and predicts patients\u2019 adverse prognosis. PLoS ONE 7:e30806","journal-title":"PLoS ONE"},{"key":"3564_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064814","volume":"8","author":"RA Droeser","year":"2013","unstructured":"Droeser RA, Hirt C, Eppenberger-Castori S et al (2013) High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor. PLoS ONE 8:e64814","journal-title":"PLoS ONE"},{"key":"3564_CR20","doi-asserted-by":"publisher","first-page":"9950","DOI":"10.1093\/nar\/gkz727","volume":"47","author":"J Amato","year":"2019","unstructured":"Amato J, Cerofolini L, Brancaccio D et al (2019) Insights into telomeric g-quadruplex DNA recognition by hmgb1 protein. Nucleic Acids Res 47:9950\u20139966","journal-title":"Nucleic Acids Res"},{"key":"3564_CR21","first-page":"4183157","volume":"2019","author":"Y Wang","year":"2019","unstructured":"Wang Y, Jiang Z, Yan J et al (2019) Hmgb1 as a potential biomarker and therapeutic target for malignant mesothelioma. Dis Markers 2019:4183157","journal-title":"Dis Markers"},{"key":"3564_CR22","doi-asserted-by":"publisher","first-page":"153303382094805","DOI":"10.1177\/1533033820948054","volume":"19","author":"XH Wang","year":"2020","unstructured":"Wang XH, Zhang SY, Shi M et al (2020) Hmgb1 promotes the proliferation and metastasis of lung cancer by activating the wnt\/\u03b2-catenin pathway. Technol Cancer Res Treat 19:1533033820948054","journal-title":"Technol Cancer Res Treat"},{"key":"3564_CR23","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1002\/art.11028","volume":"48","author":"R Pullerits","year":"2003","unstructured":"Pullerits R, Jonsson IM, Verdrengh M et al (2003) High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis. Arthritis Rheum 48:1693\u20131700","journal-title":"Arthritis Rheum"},{"key":"3564_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00894-6","author":"D Tang","year":"2023","unstructured":"Tang D, Kang R, Zeh HJ et al (2023) The multifunctional protein hmgb1: 50 years of discovery. Nature Rev Immunol. https:\/\/doi.org\/10.1038\/s41577-023-00894-6","journal-title":"Nature Rev Immunol"},{"key":"3564_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrrheum.2011.222","volume":"8","author":"HE Harris","year":"2012","unstructured":"Harris HE, Andersson U, Pisetsky DS (2012) Hmgb1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nat Rev Rheumatol 8:195\u2013202","journal-title":"Nat Rev Rheumatol"},{"key":"3564_CR26","doi-asserted-by":"publisher","first-page":"L342","DOI":"10.1152\/ajplung.00151.2012","volume":"304","author":"JM Tadie","year":"2013","unstructured":"Tadie JM, Bae HB, Jiang S et al (2013) Hmgb1 promotes neutrophil extracellular trap formation through interactions with toll-like receptor 4. Am J Physiol Lung Cell Mol Physiol 304:L342-349","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"3564_CR27","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.ccell.2022.10.008","volume":"40","author":"S Salcher","year":"2022","unstructured":"Salcher S, Sturm G, Horvath L et al (2022) High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer. Cancer Cell 40:1503-1520.e1508","journal-title":"Cancer Cell"},{"key":"3564_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler A, Hoffman P, Smibert P et al (2018) Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol 36:411\u2013420","journal-title":"Nat Biotechnol"},{"key":"3564_CR29","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/s41592-018-0229-2","volume":"15","author":"R Lopez","year":"2018","unstructured":"Lopez R, Regier J, Cole MB et al (2018) Deep generative modeling for single-cell transcriptomics. Nat Methods 15:1053\u20131058","journal-title":"Nat Methods"},{"key":"3564_CR30","doi-asserted-by":"publisher","first-page":"5024","DOI":"10.1038\/s41467-021-25240-z","volume":"12","author":"VC Sinha","year":"2021","unstructured":"Sinha VC, Rinkenbaugh AL, Xu M et al (2021) Single-cell evaluation reveals shifts in the tumor-immune niches that shape and maintain aggressive lesions in the breast. Nat Commun 12:5024","journal-title":"Nat Commun"},{"key":"3564_CR31","doi-asserted-by":"publisher","first-page":"4376","DOI":"10.1038\/s41467-019-12235-0","volume":"10","author":"D DeTomaso","year":"2019","unstructured":"DeTomaso D, Jones MG, Subramaniam M et al (2019) Functional interpretation of single cell similarity maps. Nat Commun 10:4376","journal-title":"Nat Commun"},{"key":"3564_CR32","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y et al (2012) Clusterprofiler: an r package for comparing biological themes among gene clusters. OMICS 16:284\u2013287","journal-title":"OMICS"},{"key":"3564_CR33","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/2159-8290.CD-21-0316","volume":"12","author":"Y Wu","year":"2022","unstructured":"Wu Y, Yang S, Ma J et al (2022) Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level. Cancer Discov 12:134\u2013153","journal-title":"Cancer Discov"},{"key":"3564_CR34","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar S, Gonz\u00e1lez-Blas CB, Moerman T et al (2017) Scenic: Single-cell regulatory network inference and clustering. Nat Methods 14:1083\u20131086","journal-title":"Nat Methods"},{"key":"3564_CR35","doi-asserted-by":"publisher","first-page":"765","DOI":"10.21105\/joss.00765","volume":"3","author":"H-G Drost","year":"2018","unstructured":"Drost H-G (2018) Philentropy: information theory and distance quantification with r. J Open Source Softw 3:765","journal-title":"J Open Source Softw"},{"key":"3564_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J (2013) Gsva: gene set variation analysis for microarray and rna-seq data. BMC Bioinformatics 14:7","journal-title":"BMC Bioinformatics"},{"key":"3564_CR37","unstructured":"https:\/\/scholar.google.com\/scholar?q=survminer:+Drawing+Survival+Curves+using+%27ggplot2%27&hl=zh-CN&as_sdt=0,5&as_vis=1"},{"key":"3564_CR38","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41586-022-05443-0","volume":"612","author":"R Kim","year":"2022","unstructured":"Kim R, Hashimoto A, Markosyan N et al (2022) Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nature 612:338\u2013346","journal-title":"Nature"},{"key":"3564_CR39","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41556-022-01053-0","volume":"25","author":"CA Mitchell","year":"2023","unstructured":"Mitchell CA, Verovskaya EV, Calero-Nieto FJ et al (2023) Stromal niche inflammation mediated by il-1 signalling is a targetable driver of haematopoietic ageing. Nat Cell Biol 25:30\u201341","journal-title":"Nat Cell Biol"},{"key":"3564_CR40","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1182\/blood-2017-03-770164","volume":"130","author":"LR Prince","year":"2017","unstructured":"Prince LR, Prosseda SD, Higgins K et al (2017) Nr4a orphan nuclear receptor family members, nr4a2 and nr4a3, regulate neutrophil number and survival. Blood 130:1014\u20131025","journal-title":"Blood"},{"key":"3564_CR41","doi-asserted-by":"publisher","first-page":"5893","DOI":"10.1172\/JCI136466","volume":"130","author":"Z Guo","year":"2020","unstructured":"Guo Z, Wang G, Wu B et al (2020) Dcaf1 regulates treg senescence via the ros axis during immunological aging. J Clin Investig 130:5893\u20135908","journal-title":"J Clin Investig"},{"key":"3564_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104499","volume":"90","author":"CY Wang","year":"2023","unstructured":"Wang CY, Lin TT, Hu L et al (2023) Neutrophil extracellular traps as a unique target in the treatment of chemotherapy-induced peripheral neuropathy. EBioMedicine 90:104499","journal-title":"EBioMedicine"},{"key":"3564_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109019","volume":"238","author":"H Pan","year":"2022","unstructured":"Pan H, Pan J, Li P et al (2022) Characterization of panoptosis patterns predicts survival and immunotherapy response in gastric cancer. Clin Immunol (Orlando, Fla) 238:109019","journal-title":"Clin Immunol (Orlando, Fla)"},{"key":"3564_CR44","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.1111\/bph.15904","volume":"179","author":"L Fan","year":"2022","unstructured":"Fan L, Liu H, Zhu G et al (2022) Caspase-4\/11 is critical for angiogenesis by repressing notch1 signalling via inhibiting \u03b3-secretase activity. Br J Pharmacol 179:4809\u20134828","journal-title":"Br J Pharmacol"},{"key":"3564_CR45","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327909","author":"C Conche","year":"2023","unstructured":"Conche C, Finkelmeier F, Pe\u0161i\u0107 M et al (2023) Combining ferroptosis induction with mdsc blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade. Gut. https:\/\/doi.org\/10.1136\/gutjnl-2022-327909","journal-title":"Gut"},{"key":"3564_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2023.01.016","author":"O Qiao","year":"2023","unstructured":"Qiao O, Wang X, Wang Y et al (2023) Ferroptosis in acute kidney injury following crush syndrome: a novel target for treatment. J Adv Res. https:\/\/doi.org\/10.1016\/j.jare.2023.01.016","journal-title":"J Adv Res"},{"key":"3564_CR47","doi-asserted-by":"publisher","first-page":"102614","DOI":"10.1016\/j.redox.2023.102614","volume":"60","author":"AG Gauthier","year":"2023","unstructured":"Gauthier AG, Lin M, Zefi S et al (2023) Gat107-mediated \u03b17 nicotinic acetylcholine receptor signaling attenuates inflammatory lung injury and mortality in a mouse model of ventilator-associated pneumonia by alleviating macrophage mitochondrial oxidative stress via reducing mnsod-s-glutathionylation. Redox Biol 60:102614","journal-title":"Redox Biol"},{"key":"3564_CR48","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/ni.2376","volume":"13","author":"S Chiba","year":"2012","unstructured":"Chiba S, Baghdadi M, Akiba H et al (2012) Tumor-infiltrating dcs suppress nucleic acid-mediated innate immune responses through interactions between the receptor tim-3 and the alarmin hmgb1. Nat Immunol 13:832\u2013842","journal-title":"Nat Immunol"},{"key":"3564_CR49","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.immuni.2021.04.019","volume":"54","author":"P\u00c1 de Mingo","year":"2021","unstructured":"de Mingo P\u00c1, H\u00e4nggi K, Celias DP et al (2021) The inhibitory receptor tim-3 limits activation of the cgas-sting pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake. Immunity 54:1154-1167.e1157","journal-title":"Immunity"},{"key":"3564_CR50","unstructured":"National center for biotechnology information. https:\/\/www.ncbi.nlm.nih.gov\/"},{"key":"3564_CR51","unstructured":"Jaspar. 2023: https:\/\/jaspar.genereg.net\/"},{"issue":"4","key":"3564_CR52","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41568-022-00546-2","volume":"23","author":"ST Barry","year":"2023","unstructured":"Barry ST, Gabrilovich DI, Sansom OJ et al (2023) Therapeutic targeting of tumour myeloid cells. Nature Rev Cancer 23(4):216\u2013237","journal-title":"Nature Rev Cancer"},{"issue":"7","key":"3564_CR53","doi-asserted-by":"publisher","first-page":"e161084","DOI":"10.1172\/JCI161084","volume":"133","author":"G Tunal\u0131","year":"2023","unstructured":"Tunal\u0131 G, R\u00fabies Bed\u00f3s M, Nagarajan D et al (2023) Interleukin-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy. J Clin Invest 133(7):e161084","journal-title":"J Clin Invest"},{"key":"3564_CR54","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","volume":"612","author":"R Xue","year":"2022","unstructured":"Xue R, Zhang Q, Cao Q et al (2022) Liver tumour immune microenvironment subtypes and neutrophil heterogeneity. Nature 612:141\u2013147","journal-title":"Nature"},{"key":"3564_CR55","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13073-023-01164-9","volume":"15","author":"J Hu","year":"2023","unstructured":"Hu J, Zhang L, Xia H et al (2023) Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell rna sequencing. Genome Med 15:14","journal-title":"Genome Med"},{"key":"3564_CR56","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12307-014-0147-5","volume":"8","author":"RV Sionov","year":"2015","unstructured":"Sionov RV, Fridlender ZG, Granot Z (2015) The multifaceted roles neutrophils play in the tumor microenvironment Cancer microenvironment\u202f: official journal of the International. Cancer Microenviron Soc 8:125\u2013158","journal-title":"Cancer Microenviron Soc"},{"issue":"6","key":"3564_CR57","doi-asserted-by":"publisher","first-page":"e143759","DOI":"10.1172\/JCI143759","volume":"131","author":"AJ McFarlane","year":"2021","unstructured":"McFarlane AJ, Fercoq F, Coffelt SB, Carlin LM (2021) Neutrophil dynamics in the tumor microenvironment. J Clin Invest 131(6):e143759","journal-title":"J Clin Invest"},{"key":"3564_CR58","doi-asserted-by":"publisher","first-page":"5972","DOI":"10.3390\/cancers13235972","volume":"13","author":"E Taucher","year":"2021","unstructured":"Taucher E, Taucher V, Fink-Neuboeck N et al (2021) Role of tumor-associated neutrophils in the molecular carcinogenesis of the lung. Cancers 13:5972","journal-title":"Cancers"},{"key":"3564_CR59","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ccell.2016.06.001","volume":"30","author":"S Singhal","year":"2016","unstructured":"Singhal S, Bhojnagarwala PS, O\u2019Brien S et al (2016) Origin and role of a subset of tumor-associated neutrophils with antigen-presenting cell features in early-stage human lung cancer. Cancer Cell 30:120\u2013135","journal-title":"Cancer Cell"},{"key":"3564_CR60","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00262-017-1976-0","volume":"66","author":"EB Eruslanov","year":"2017","unstructured":"Eruslanov EB (2017) Phenotype and function of tumor-associated neutrophils and their subsets in early-stage human lung cancer. Cancer Immunol, Immunotherap: CII 66:997\u20131006","journal-title":"Cancer Immunol, Immunotherap: CII"},{"key":"3564_CR61","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1182\/blood-2018-11-844548","volume":"133","author":"MA Giese","year":"2019","unstructured":"Giese MA, Hind LE, Huttenlocher A (2019) Neutrophil plasticity in the tumor microenvironment. Blood 133:2159\u20132167","journal-title":"Blood"},{"key":"3564_CR62","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.it.2016.03.005","volume":"37","author":"JM Adrover","year":"2016","unstructured":"Adrover JM, Nicol\u00e1s-\u00c1vila JA, Hidalgo A (2016) Aging: a temporal dimension for neutrophils. Trends Immunol 37:334\u2013345","journal-title":"Trends Immunol"},{"key":"3564_CR63","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","volume":"20","author":"S Jaillon","year":"2020","unstructured":"Jaillon S, Ponzetta A, Di Mitri D et al (2020) Neutrophil diversity and plasticity in tumour progression and therapy. Nat Rev Cancer 20:485\u2013503","journal-title":"Nat Rev Cancer"},{"key":"3564_CR64","doi-asserted-by":"publisher","first-page":"1007812","DOI":"10.3389\/fimmu.2022.1007812","volume":"13","author":"Q Hu","year":"2022","unstructured":"Hu Q, Wu G, Wang R et al (2022) Cutting edges and therapeutic opportunities on tumor-associated macrophages in lung cancer. Front Immunol 13:1007812","journal-title":"Front Immunol"},{"key":"3564_CR65","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","volume":"30","author":"X He","year":"2020","unstructured":"He X, Xu C (2020) Immune checkpoint signaling and cancer immunotherapy. Cell Res 30:660\u2013669","journal-title":"Cell Res"},{"key":"3564_CR66","first-page":"6799","volume":"15","author":"L Wu","year":"2018","unstructured":"Wu L, Yang L (2018) The function and mechanism of hmgb1 in lung cancer and its potential therapeutic implications. Oncol Lett 15:6799\u20136805","journal-title":"Oncol Lett"},{"key":"3564_CR67","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.2147\/OTT.S104409","volume":"9","author":"Q Xia","year":"2016","unstructured":"Xia Q, Xu J, Chen H et al (2016) Association between an elevated level of hmgb1 and non-small-cell lung cancer: a meta-analysis and literature review. Onco Targets Ther 9:3917\u20133923","journal-title":"Onco Targets Ther"},{"key":"3564_CR68","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/sj.emboj.7601552","volume":"26","author":"VV Orlova","year":"2007","unstructured":"Orlova VV, Choi EY, Xie C et al (2007) A novel pathway of hmgb1-mediated inflammatory cell recruitment that requires mac-1-integrin. EMBO J 26:1129\u20131139","journal-title":"EMBO J"},{"key":"3564_CR69","first-page":"219","volume":"38","author":"NS Mohammad","year":"2022","unstructured":"Mohammad NS, Nazli R, Zafar H et al (2022) Effects of lipid based multiple micronutrients supplement on the birth outcome of underweight pre-eclamptic women: a randomized clinical trial. Pakistan J Med Sci 38:219\u2013226","journal-title":"Pakistan J Med Sci"},{"key":"3564_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.823618","volume":"13","author":"H Mamdani","year":"2022","unstructured":"Mamdani H, Matosevic S, Khalid AB et al (2022) Immunotherapy in lung cancer: current landscape and future directions. Front Immunol 13:823618","journal-title":"Front Immunol"},{"key":"3564_CR71","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck M, Rodr\u00edguez-Abreu D, Robinson AG et al (2016) Pembrolizumab versus chemotherapy for pd-l1-positive non-small-cell lung cancer. N Engl J Med 375:1823\u20131833","journal-title":"N Engl J Med"},{"issue":"2","key":"3564_CR72","doi-asserted-by":"publisher","first-page":"e160025","DOI":"10.1172\/JCI160025","volume":"133","author":"S Ando","year":"2023","unstructured":"Ando S, Perkins CM, Sajiki Y et al (2023) Mtor regulates t cell exhaustion and pd-1-targeted immunotherapy response during chronic viral infection. J Clin Invest 133(2):e160025","journal-title":"J Clin Invest"},{"key":"3564_CR73","doi-asserted-by":"publisher","first-page":"e20211431","DOI":"10.1084\/jem.20211431","volume":"220","author":"SC Edwards","year":"2023","unstructured":"Edwards SC, Hedley A, Hoevenaar WHM et al (2023) Pd-1 and tim-3 differentially regulate subsets of mouse il-17a-producing \u03b3\u03b4 t cells. J Experiment Med 220:e20211431","journal-title":"J Experiment Med"},{"key":"3564_CR74","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41586-021-03626-9","volume":"595","author":"KO Dixon","year":"2021","unstructured":"Dixon KO, Tabaka M, Schramm MA et al (2021) Tim-3 restrains anti-tumour immunity by regulating inflammasome activation. Nature 595:101\u2013106","journal-title":"Nature"},{"key":"3564_CR75","doi-asserted-by":"publisher","first-page":"e005548","DOI":"10.1136\/jitc-2022-005548","volume":"10","author":"M Natoli","year":"2022","unstructured":"Natoli M, Hatje K, Gulati P et al (2022) Deciphering molecular and cellular ex vivo responses to bispecific antibodies pd1-tim3 and pd1-lag3 in human tumors. J Immunotherap Cancer 10:e005548","journal-title":"J Immunotherap Cancer"},{"issue":"13","key":"3564_CR76","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1158\/1078-0432.CCR-20-4746","volume":"27","author":"G Curigliano","year":"2021","unstructured":"Curigliano G, Gelderblom H, Mach N, Doi T, Tai D, Forde PM, Naing A (2021) Phase I\/Ib clinical trial of sabatolimab, an anti\u2013TIM-3 antibody, alone and in combination with spartalizumab, an anti\u2013PD-1 antibody, in advanced solid tumors. Clinical Cancer Research 27(13):3620\u20133629","journal-title":"Clinical Cancer Research"},{"issue":"Supplement 1","key":"3564_CR77","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1182\/blood-2022-158612","volume":"140","author":"AM Zeidan","year":"2022","unstructured":"Zeidan AM, Ando K, Rauzy O, Turgut M, Wang MC, Cairoli R, Platzbecker U (2022) primary results of stimulus-mds1: A randomized, double-blind, placebo-controlled phase ii study of tim-3 inhibition with sabatolimab added to hypomethylating agents (hmas) in adult patients with higher-risk myelodysplastic syndromes (mds). Blood 140(Supplement 1):2063\u20132065","journal-title":"Blood"},{"key":"3564_CR78","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/ni.2396","volume":"13","author":"D Tang","year":"2012","unstructured":"Tang D, Lotze MT (2012) Tumor immunity times out: Tim-3 and hmgb1. Nat Immunol 13:808\u2013810","journal-title":"Nat Immunol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-023-03564-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-023-03564-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-023-03564-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T03:05:02Z","timestamp":1701918302000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-023-03564-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":78,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["3564"],"URL":"https:\/\/doi.org\/10.1007\/s00262-023-03564-7","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]},"assertion":[{"value":"13 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}